Oral bifosfonat tedavisi görmüş olan bir hastanın dental implant destekli protez ile rehabilitasyonu: Olgu sunumu
Öz
Bifosfonatlar kemik metabolizmasında osteoklastik inhibitör etkileri nedeniyle birçok kemik ile ilgili hastalıkta yaygın olarak kullanılmaktadır. Son yıllarda intravenöz (İV) ve oral yolla alınan bifosfonatların, ciddi bir yan etkisi olan bifosfonata bağlı çenelerde görülen osteonekroz (BRONJ) hakkında bir çok vaka rapor edilmiştir. BRONJ oluşturma riski yüksek olması nedeniyle İV bifosfonat kullanımı, dental implant uygulamalarında kesin kontraendikasyon olduğu bildirilmiştir. Ancak oral bifosfonat kullanan hastalarda dental implant yapılması ile ilgili öneriler sınırlı verilere dayanmaktadır. Bu olgu raporunda, osteoporoz nedeniyle 3 yıl bifosfonat tedavisi görmüş olan hastanın dental implant destekli protez ile rehabilitasyonu sunulmuştur.
Anahtar Kelimeler
Kaynakça
- Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaw, American American Association of Oral and Maxillofacial Surgeons, 2007. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg, 65, 369-376.
- Assael LA, 2009. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg, 67, 35-43.
- Bedogni A, Bettini G, Totola A, Saia G and Nocini PF, 2010. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review. J Oral Maxillofac Surg, 68, 1662-1666.
- Bell BM and Bell RE, 2008. Oral bisphosphonates and dental implants: a retrospective study. J Oral Maxillofac Surg, 66, 1022-1024.
The rehabilitation of a patient who received oral bisphosphonate treatment with dental implant supported prosthesis: A case report
Öz
Bisphosphonates are widely used in many bone diseases due to
their efficient osteoclastic inhibitor effect on bone metabolism. In
recent years, numerous cases of bisphosphonate-associated
osteonecrosis of the jaw (BRONJ) have been reported as a side
effect of both intravenous (IV) and oral therapy regimens. IV
administration of bisphosphonates has been considered an
absolute contraindication for placement of dental implants due
to the increased risk of BRONJ. However, the recommendations
were based on limited data about dental implant placement in
patients taking oral bisphosphonates. This report documents
the rehabilitation of an osteoporotic patient had treated with oral
bisphosphonate for 3 years by dental implant supported
prosthesis.
Anahtar Kelimeler
Kaynakça
- Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaw, American American Association of Oral and Maxillofacial Surgeons, 2007. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg, 65, 369-376.
- Assael LA, 2009. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg, 67, 35-43.
- Bedogni A, Bettini G, Totola A, Saia G and Nocini PF, 2010. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review. J Oral Maxillofac Surg, 68, 1662-1666.
- Bell BM and Bell RE, 2008. Oral bisphosphonates and dental implants: a retrospective study. J Oral Maxillofac Surg, 66, 1022-1024.
Ayrıntılar
| Diğer ID | JA82FN88NA |
|---|---|
| Bölüm | Olgu Sunumu |
| Yazarlar | |
| Yayımlanma Tarihi | 1 Ağustos 2016 |
| Gönderilme Tarihi | 1 Ağustos 2016 |
| Yayımlandığı Sayı | Yıl 2016 Cilt: 3 Sayı: 2 |
Selcuk Dental Journal Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı (CC BY NC) ile lisanslanmıştır.